| Date Filed | Type | Description |
| 08/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/15/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2023 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 2.6% stake in AGM Group Holdings Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Cingulate Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Context Therapeutics Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0.6% stake in Tantech Holdings Ltd |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 3.4% stake in Heartbeam, Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in Recon Technology, Ltd. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 3.8% stake in Bit Digital, Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 8.4% stake in Virpax Pharmaceuticals, Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5% stake in PharmaCyte Biotech, Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 5.2% stake in Cocrystal Pharma, Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 8.3% stake in Pulmatrix, Inc. |
| 01/10/2023 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0% stake in Rebus Holdings, Inc. |
| 01/04/2023 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 10% stake in BiondVax Pharmaceuticals Ltd. |
| 01/04/2023 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 8.4% stake in RedHill Biopharma Ltd. |
| 01/04/2023 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 10% stake in TuanChe Limited |
| 01/04/2023 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 10% stake in Huadi International Group Co., Ltd. |
| 01/04/2023 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 10% stake in Kiromic BioPharma, Inc. |
| 01/04/2023 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 5.8% stake in Quanergy Systems, Inc. |
| 01/04/2023 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 5.5% stake in Avenue Therapeutics, Inc. |
| 01/04/2023 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 8.1% stake in Bone Biologics Corp |
| 01/04/2023 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 10% stake in Aditxt, Inc. |
| 01/04/2023 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 9.4% stake in Neptune Wellness Solutions Inc. |
| 01/04/2023 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 10% stake in ToughBuilt Industries, Inc. |
| 01/04/2023 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 6.9% stake in Dogness Corporation |
| 01/04/2023 |
SC 13G
| SABBY MANAGEMENT, LLC reports a 7.8% stake in Blue Water Vaccines, Inc. |
| 11/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 08/15/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 05/16/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 02/14/2022 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 01/05/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0.4% stake in Skye Bioscience, Inc. |
| 01/05/2022 |
SC 13G/A
| SABBY MANAGEMENT, LLC reports a 0% stake in Reviva Pharmaceuticals Holdings, Inc. |
|